Fulcrum Therapeutics Inc. (FULC)
NASDAQ · Healthcare
Fulcrum Therapeutics Inc. Revenue 2020–2025
Fulcrum Therapeutics Inc. annual/quarterly revenue history and growth rate from 2020 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Fulcrum Therapeutics Inc. revenue for the quarter ending September 30, 2025 was 0.
- Fulcrum Therapeutics Inc. revenue for the twelve months ending September 30, 2025 was 80.0 M, a 4036.50% increase year-over-year.
- Fulcrum Therapeutics Inc. annual revenue for 2025 was 0, a 100.00% decrease from 2024.
- Fulcrum Therapeutics Inc. annual revenue for 2024 was 80.0 M, a 2752.05% increase from 2023.
- Fulcrum Therapeutics Inc. annual revenue for 2023 was 2.8 M, a 55.77% decrease from 2022.
- Fulcrum Therapeutics Inc. annual revenue for 2022 was 6.3 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Fulcrum Therapeutics Inc. Market Cap — FAQ
Fulcrum Therapeutics Inc. (FULC) market cap over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FULC's market cap history?
The chart and table above show Fulcrum Therapeutics Inc.'s market cap by year and by quarter, including the growth rate.